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Method: Hip fracture datasheets from 2019 in six Dublin hospitals were
analysed.
Results: 1,284 hip fractures in total were recorded in 2019 in these six
hospitals. 112 of these were second hip fractures (8.72%). 24.1% of
patients had a HF2 in year 1 post their first hip fracture (HF1). 14.3% of
patients had a HF2 in Year 2, 8% in Year 3, 8.9% in Year 4 and 6.3% in
Year 5. 17.9% of patients had an HF2 at an unknown time in relation to
their HF1. 57.6% of all patients with any hip fracture were started on
bone protection medications (BPMs) during their admission. 18.9% con-
tinued a pre-admission prescription. 7% of all patients were previously
assessed and determined not to require BPM. 6.9% of patients were
awaiting outpatient department (OPD) assessment for bone protection.
8.6% had no assessment for bone protection conducted. Of all patients
with an HF2, 48.2% were started on BPMs on admission with their HF2.
33% continued BPMs started pre-admission.
Discussion: In 2019, approximately 1 in 10 hip fractures were
second hip fractures. Evidence suggests that fracture liaison services
whilst also identifying areas of future research
Method: This scoping review was guided by the methodological frame-
work of the Joanna Briggs institute. A computer-based search was con-
ducted in PubMed, EMBASE, MEDLINE, Emcare and CINAHL, for articles
reporting treatment of chronic tibial/femoral osteomyelitis. Title/ab-
stract and full text screening was performed independently by two
reviewers according to pre-defined criteria.
Results: A total of 1223 articles were identified, with 40 studies, involv-
ing 2,489 patients being finally included. A range of treatments are
reported, with the key reported principles being removal of infected tis-
sue, dead-space management and antibiotic therapy. The majority
(76.2%) of patients presented with stage III or IV disease according to
the Cierny-Mader classification and the most commonly cultured path-
ogen was Staphylococcus aureus. The proportion of patients achieving
remission with no recurrence during follow up varies from 72.0% -
100.0%.
Conclusions: The majority of studies report excellent outcomes in
terms of infection remission and lack of recurrence. However, using
the current literature to identify specific patient and treatment related
factors which may affect treatment results is challenging due to a
number of potential confounding factors. Further high-level research





presenting to the ED June-December 2020 and subsequently referred on
to VFC. Patient demographics and clinic outcomes were reviewed using
electronic patient records and radiographs.
Results: Fifty patients were identified (Male:Female 37:13; mean age 26
years, range 3-89 years). Of these, 41/50 were discharged directly fol-
lowing VFC advice, with no adverse event. The remaining 9/50 had a
face-to-face Fracture Clinic review due to safeguarding concerns (2),
concurrent neck of fourth MC fracture (2), concerns regarding fracture
pattern (4), and an unclear indication (1). These 9/50 were discharged
after single review, with no adverse events to date.
Conclusions: Our data suggest that VFC review of patients with little
MC neck fractures is a safe and feasible means of patient care which
has the potential to reduce the requirement of face-to-face patient con-
tact during the Covid-19 pandemic and reduce fracture clinic atten-
dance. We suggest the routine incorporation of a Virtual Fracture Clinic
for these hand injuries. Further work is needed to formally investigate
associated patient satisfaction and the application of this approach to
other trauma presentations.
1260 Comparison of the Intramedullary Nail and Dynamic
Hip Screw in the Management of Subtrochanteric Femoral
DHS. These groups were compared on outcome measures including ra-
diation dose area product (DAP), length of hospital stay, estimated
blood loss, mortality, and re-operation/complication rate.
Results: A total of 86 patients presented to our institution with a sub-
trochanteric femoral fracture during the study time period. Of these, 74
(86%) received an IMN and the remaining 12 (14%) received a DHS. The
only comparative outcome measures showing a statistically significant
difference between the two groups were radiation DAP and blood loss.,
both of which were significantly lower in the DHS group. All other com-
parative outcome measures failed to reach statistical significance.
Conclusions: Although current United Kingdom national guidelines
advise all subtrochanteric femoral fractures should be treated with an
IMN, the outcome measures used in this study suggest that the DHS,
which also has a reduced implant cost compared to an IMN, may be the
better option in some cases. There may not be one optimal implant for
all subtrochanteric fractures. Recent biomechanical research suggests
that the DHS is able to provide adequate fixation in more stable fracture
subtypes, whereas an IMN may be required for unstable subtrochan-
teric fractures.
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Introduction: Limited data are available on the influence of multimor-
bidity on the outcomes of total hip replacement for patients with hip
osteoarthritis. Thus, patients with multimorbidity and their clinicians
across the UK are making decisions on whether or not to proceed with
total hip replacement without clear information available on the po-
tential risks and benefits. It is not known how such patients are cur-
rently managed. The aim of this study was to investigate the influence
of multimorbidity on the likelihood of receiving total hip replacement
in patients with hip osteoarthritis in the UK.
Method: A cohort study was performed, with cohort comprised of all
patients over 65 years with a diagnosis of hip osteoarthritis recorded in
Clinical Practice Research Datalink. Severity of multimorbidity burden
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was measured using four different scores (Charlson Comorbidity Index,
Electronic Frailty Index, count of drugs prescribed, count of primary
care interactions). The outcome was total hip replacement, evaluated
using Kaplan-Meier survival and competing-risk analyses.
Results: 28,025 patients were included. 10,948 patients underwent total
hip replacement. Increased multimorbidity burden was associated
with decreased likelihood of undergoing surgery, irrespective of the
method of scoring multimorbidity. Electronic Frailty Index had the larg-
est difference between categories. Adjusted hazard ratio (‘severe multi-
morbidity versus ‘fit’) was 0.34 (95% CI 0.22, 0.51).
Conclusions: Patients with hip osteoarthritis and concurrent multi-
morbidity were up to two thirds less likely to undergo total hip replace-
ment. Whether this difference in healthcare management is
appropriate depends on to what extent multimorbidity influences the
outcomes of total hip replacement.
multimorbidity on the outcomes of total hip replacement in the UK.
Method: A cohort study was performed, with cohort comprised of all
patients over 65 years with a diagnosis of hip osteoarthritis recorded in
Clinical Practice Research Datalink and receipt of primary total hip re-
placement recorded in Hospital Episode Statistics Admitted Patient
Care. Severity of multimorbidity burden was measured using four dif-
ferent scores (Charlson Comorbidity Index, Electronic Frailty Index,
count of drugs prescribed, count of primary care interactions). The out-
comes were (i) the risks of total hip replacement, assessed by serious
post-operative complications within 90 days (analysed with logistic re-
gression), and (ii) the benefits of surgery, assessed by post-operative
Oxford Hip Score (OHS) and EQ-5D quality of life score (analysed with
linear regression).
Results: 6,682 patients were included. The rate of complications was
3.2%. Patients with severe multimorbidity burden were at 1.5 to 2.5
times increased risk of complications than patients without multimor-
bidity. There was no clinically meaningful difference in the benefits of
surgery between patients with and without multimorbidity, irrespec-
tive of the method of scoring multimorbidity.
Conclusions: Even for patients with severe multimorbidity burden, the
potential benefits of total hip replacement for osteoarthritis remain
substantial, while the increase in risk is relatively small.






















physical fracture clinics (PFC) was assessed.
Method: Outcomes of 1st attendances were collected for standard
PFC’s before the implementation of the VFC at our centre. This data
was comparatively analysed to the outcomes of 1st ‘attendances’ of
VFCs post-service implementation. To assess VFC referral quality frac-
ture type was recorded and compared to the standard set out by the
Glasgow virtual fracture pathway which states that a selection of sim-
ple stable fractures should be discharged from ED directly with patient
advice and telephone support.







ent_6/znab259.1038/6388828 by guest on 13 D
ecem
ber 2021
